Gerresheimer recently unveiled its formula G strategy process and levers for sustainable, profitable growth, describing its high value solutions, investment plans, innovation and digitalisation strategy, as well as its ambitious sustainability goals. “We are transforming Gerresheimer into a growth value ass an innovation leader and solution provider” explained Dietmar Siemssen, CEO of Gerresheimer AG. “Within our strategic process formula G, we have set ambitious targets. With the right mindset for growth and by mobilising the entire company, we will achieve the targets.”

Gerresheimer anticipates global megatrends for pharma and healthcare, serving customers and patients worldwide with innovative solutions and the broadest portfolio of products and solutions. Increasing demand for general vaccinations and self-medication, as well as the shift from small molecules to biologics and biosimilars, will boost the market for injectables. Gerresheimer has leading market positions in injectable product solutions such as syringes, vials, pens and auto injection devices.

Ambitious sustainability targets complement the formula G growth strategy. “As well as cementing our position as a good corporate citizen, sustainability is both a growth lever and business opportunity for our company” Dietmar Siemssen explained. “It is therefore an essential part of our strategy. We have defined very ambitious sustainability targets that set new industry standards.”

www.gerresheimer.com